SJ Sung Joo Lee
Founder & CEO
Throughout his career at Sanofi and LG Chem, SJ has worked to improve the therapeutic landscape for various diseases, including hepatitis B, hepatocellular carcinoma (HCC), diabetes, and Alzheimer’s disease.
Chief Scientific Officer
Peter is a drug discovery executive working on targeted therapeutics for oncology, overseeing discovery and development of novel therapeutics based on cell-penetrating antibody platform. He is the co-inventor of Isatuximab during tenure at Immunogen.
K Ki Hwan Chang
K is an experienced biomedical scientist with a demonstrated history of discovering antibody drugs, a couple of them in clinical trials. He has held antibodies drug discovery leadership positions at CJ, GC Pharma, and Mogam.
Yong-Sung is Professor at Ajou University and a pioneer in antibody engineering for therapeutic applications. He has published more than 95 peer-reviewed articles and holds multiple domestic and international patents.